SMART Biotech

Company Overview

Snapshot

Founded in January 2004 by Yisrael Serok and Tamar Jehuda-Cohen, SMART Biotech operates with 1–10 employees. The company developed a technology platform for the early detection of infectious diseases, highlighted by an Israeli breakthrough in shortening the window of HIV detection.

Business overview

SMART Biotech develops Stimmunology, a technology platform designed to detect various infectious diseases, including HIV and HCV, within days of infection. Its core product, SMARTube, is a pre-analytic device that processes and enhances blood samples to improve the accuracy and speed of existing antibody tests. This technology reduces false positive and false negative results, distinguishes between recent and non-recent infections, and reports viral clearance. The company serves the healthcare industry, operating within the Health Tech & Life Sciences sector, specifically focusing on medical devices and diagnostics.

Strategic signal

In May 2006, SMART Biotech achieved an Israeli breakthrough in shortening the window of HIV detection. This development is significant for the medical diagnostics industry as it promises earlier diagnosis of infectious diseases, which can lead to more effective treatment and containment strategies. For investors, this signals the company's capability in developing innovative diagnostic tools with the potential to impact public health and the infectious disease screening market.

Company Intelligence Q&A

What is SMART Biotech's primary product?

SMART Biotech's primary product is SMARTube, a pre-analytic device based on its Stimmunology technology platform. It enhances blood samples to enable earlier and more accurate detection of infectious diseases using existing antibody tests.

When was SMART Biotech founded?

SMART Biotech was founded in January 2004.

Who are the founders of SMART Biotech?

The founders of SMART Biotech are Yisrael Serok, who serves as CEO, and Tamar Jehuda-Cohen, who is the Co-founder CTO.

What is the key benefit of SMART Biotech's technology?

SMART Biotech's technology, Stimmunology, allows for the detection of infectious diseases like HIV and HCV within days of infection, significantly shortening the serological window and improving the accuracy of diagnostic tests by reducing false results.

What significant breakthrough did SMART Biotech achieve in infectious disease detection?

In May 2006, SMART Biotech achieved an Israeli breakthrough in shortening the window of HIV detection, enabling earlier diagnosis of the virus.